Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Wysoglad, Hubert [1 ,2 ]
Krawczyk, Katarzyna [2 ,3 ]
Ochrem, Bogdan [2 ,3 ]
Madry, Krzysztof [1 ]
Drozd-Sokolowska, Joanna [1 ]
Sacha, Tomasz [2 ,3 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantol & Internal Med, Warsaw, Poland
[2] Univ Hosp Krakow, Dept Hematol, Krakow, Poland
[3] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
acute myeloid leukemia; azacitidine; venetoclax; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-384
引用
收藏
页码：S294 / S294
页数：1
相关论文
共 50 条
  • [31] Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy
    Bocchia, Monica
    Candoni, Anna
    Borlenghi, Erika
    Defina, Marzia
    Fili, Carla
    Cattaneo, Chiara
    Sammartano, Vincenzo
    Fanin, Renato
    Sciume, Margherita
    Sicuranza, Anna
    Imbergamo, Silvia
    Riva, Marta
    Fracchiolla, Nicola
    Latagliata, Roberto
    Caizzi, Emanuela
    Mazziotta, Francesco
    Alunni, Giulia
    Di Bona, Eros
    Crugnola, Monica
    Rossi, Marianna
    Consoli, Ugo
    Fontanelli, Giulia
    Greco, Giuseppina
    Nadali, Gianpaolo
    Rotondo, Francesco
    Todisco, Elisabetta
    Bigazzi, Catia
    Capochiani, Enrico
    Molteni, Alfredo
    Bernardi, Massimo
    Fumagalli, Monica
    Rondoni, Michela
    Scappini, Barbara
    Ermacora, Anna
    Simonetti, Federico
    Gottardi, Michele
    Deliliers, Daniela Lambertenghi
    Michieli, Mariagrazia
    Basilico, Claudia
    Galeone, Carlotta
    Pelucchi, Claudio
    Rossi, Giuseppe
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 447 - 455
  • [32] Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia
    Abernathy, Karin M.
    Perciavalle, Matthew A.
    Gatwood, Katie S.
    Chen, Heidi
    Zakhari, Matthew M.
    Byrne, Michael
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (06) : 1326 - 1333
  • [33] Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience
    Chen, Yi
    Cao, Jing
    Ye, Yaozhen
    Luo, Luting
    Zheng, Xiaoyun
    Yang, Xiaozhu
    Zheng, Zhihong
    Zheng, Jing
    Yang, Ting
    Hu, Jianda
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (04) : 322 - 329
  • [34] Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
    Laloi, Louise
    Billotey, Natacha Chaumard
    Dumas, Pierre-Yves
    Paul, Franciane
    Villate, Alban
    Simand, Celestine
    Fornecker, Luc
    Puisset, Florent
    Bertoli, Sarah
    Simonet, Marion Boissard
    Laribi, Kamel
    Houyou, Dyhia
    Santagostino, Alberto
    Michel, Claire
    Guepin, Gabrielle Roth
    Guerineau, Elodie
    Tabrizi, Reza
    Hunault, Mathilde
    Giltat, Aurelien
    Kaphan, Eleonore
    Bulabois, Claude
    Cartet, Elodie
    Rocher, Clement
    Lachenal, Florence
    Morisset, Stephane
    Recher, Christian
    Pigneux, Arnaud
    Belhabri, Amine
    Michallet, Mauricette
    Michallet, Anne-Sophie
    CANCER MEDICINE, 2023, 12 (06): : 7175 - 7181
  • [35] Venetoclax plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for elderly or unfit patients with newly diagnosed acute myeloid leukemia: a multicenter, prospective study
    Ma, Hongbing
    Du, Yiwen
    Li, Jianjun
    Rao, Jin
    Guo, Yong
    Yang, Yunfan
    Zhang, Duanzhong
    Wang, Jia
    Liao, Yi
    Gong, Yuping
    ANNALS OF HEMATOLOGY, 2024, : 5315 - 5323
  • [36] Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia
    Matthews, Andrew H.
    Perl, Alexander E.
    Luger, Selina M.
    Gill, Saar I.
    Lai, Catherine
    Porter, David L.
    Skuli, Sarah
    Bruno, Ximena Jordan
    Carroll, Martin P.
    Freyer, Craig W.
    Carulli, Alison
    Babushok, Daria V.
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Stadtmauer, Edward A.
    Loren, Alison W.
    Paralkar, Vikram R.
    Maillard, Ivan P.
    Pratz, Keith W.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1254 - 1264
  • [37] Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia
    Bewersdorf, Jan Philipp
    Patel, Kishan K. K.
    Goshua, George
    Shallis, Rory M. M.
    Podoltsev, Nikolai A. A.
    Stahl, Maximilian
    Stein, Eytan M. M.
    Huntington, Scott F. F.
    Zeidan, Amer M. M.
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 454 - 461
  • [38] Efficacy of the Combination of Venetoclax and Azacitidine in Elderly of Frail Relapsed/Refractory Patients with Acute Myeloid Leukemia, First Multi-Institutional Real World Experience from Turkey
    Aktimur, Sude Hatun
    Gunes, Ahmet Kursad
    Akidan, Osman
    Karatas, Ayse
    Turgut, Mehmet
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2020, 30 (04): : 213 - 221
  • [39] Revisiting the Real-World Prognosis of Intensive Chemotherapy in Elderly Acute Myeloid Leukemia Patients: A Retrospective Analysis from Tokyo
    Hagino, Takeshi
    Saga, Reina
    Hidai, Hiroko
    Tsutsumi, Hisashi
    Akiyama, Hideki
    Murai, Yoshiro
    Mori, Mayumi
    Motomura, Sayuri
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, : 422 - 426
  • [40] Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia
    Chen, Tzu-Ting
    Lin, Ching-Chan
    Lo, Wen-Jyi
    Hsieh, Ching-Yun
    Lein, Ming-Yu
    Lin, Che-Hung
    Lin, Chen-Yuan
    Bai, Li-Yuan
    Chiu, Chang-Fang
    Yeh, Su-Peng
    CANCERS, 2024, 16 (06)
12345